10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $439,643 | -32.5% | 10,658 | -8.6% | 0.00% | -33.3% |
| Q2 2023 | $651,318 | +111427.1% | 11,664 | +11.1% | 0.00% | 0.0% |
| Q1 2023 | $584 | +33.0% | 10,499 | -13.0% | 0.00% | +50.0% |
| Q4 2022 | $439 | -99.5% | 12,061 | +319.5% | 0.00% | – |
| Q3 2022 | $81,000 | +22.7% | 2,875 | +95.2% | 0.00% | – |
| Q2 2022 | $66,000 | -83.6% | 1,473 | -72.2% | 0.00% | -100.0% |
| Q1 2022 | $402,000 | -48.5% | 5,308 | +1.1% | 0.00% | -50.0% |
| Q4 2021 | $781,000 | +24.2% | 5,249 | +21.3% | 0.00% | +33.3% |
| Q3 2021 | $629,000 | -83.2% | 4,328 | -77.4% | 0.00% | -85.7% |
| Q2 2021 | $3,750,000 | +115.4% | 19,165 | +99.0% | 0.02% | +75.0% |
| Q1 2021 | $1,741,000 | -4.2% | 9,631 | -25.1% | 0.01% | -14.3% |
| Q4 2020 | $1,818,000 | +42.9% | 12,859 | +25.8% | 0.01% | +16.7% |
| Q3 2020 | $1,272,000 | +648.2% | 10,220 | +435.6% | 0.01% | +500.0% |
| Q2 2020 | $170,000 | +23.2% | 1,908 | -13.9% | 0.00% | 0.0% |
| Q1 2020 | $138,000 | – | 2,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |